Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma.

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; High-Throughput Nucleotide Sequencing/High-Throughput Nucleotide Sequencing/High-Throughput Nucleotide Sequencing/*methods ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

  • Source: Leukemia [Leukemia] 2017 Jun; Vol. 31 (6), pp. 1446-1449. Date of Electronic Publication: 2017 Feb 17.Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-1 of  1 نتائج ل ""Ruiz-Heredia Y.""